Pulsed electromagnetic fields for postoperative pain: a randomized controlled clinical trial in patients undergoing mandibular third molar extraction

Stocchero, Michele; Gobbato, Luca; Biagi, Marleen De; Bressan, Eriberto

doi:10.1016/j.oooo.2014.11.017

Cited by 19 publications

(18 citation statements)

References 39 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other studies that used PEMF in oral and plastic surgeries also reported that PEMF therapy accelerated wound healing and tissue repair (9)(10)(11).…”

Section: Discussionmentioning

confidence: 95%

“…Thus, in the studies of Heden et al and Rohde et al PEMF treatment provided good pain control and reduced narcotic use postoperatively in breast augmentation and reduction surgeries(10,11). In addition in the Stocchero et al study, PEMF treatment significantly reduced the pain after mandibular third molar extraction(9).…”

mentioning

confidence: 94%

“…used PEMF-treatment after oral surgery (9). Several pathways have been proposed for the antiinflammatory and analgesic effects of PEMF treatment including the effects of PEMF signals on increasing anti-inflammatory cytokines, endogenous analgesic agents and endogenous opioid precursor proteins, and decreasing pro-inflammatory cytokines and endogenous hyperalgesic agents (10,15).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pulsed Electromagnetic Fields for Postsurgical Pain Management in Women Undergoing Cesarean Section

Khooshideh

Rostami

Sheikh

et al. 2017

The Clinical Journal of Pain

View full text Add to dashboard Cite

show abstract

“…Other studies that used PEMF in oral and plastic surgeries also reported that PEMF therapy accelerated wound healing and tissue repair (9)(10)(11).…”

Section: Discussionmentioning

confidence: 95%

mentioning

confidence: 94%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pulsed Electromagnetic Fields for Postsurgical Pain Management in Women Undergoing Cesarean Section

Khooshideh

Rostami

Sheikh

et al. 2017

The Clinical Journal of Pain

View full text Add to dashboard Cite

show abstract

“…A lack of a placebo control is a limitation in this study, but it is now being acknowledge that the placebo effect is built-in to any given treatment [46]. Prior chronic pain placebo controlled trials using this device reported modest placebo effects [29,30] and the device performs better than placebo in acute pain studies [27,28,47] suggesting that the e cacy of the device is not only driven solely by the placebo effect. Furthermore in this study we nd the reduction in e cacy of both treatments being associated with the subject's BMI, especially for the PSWT arm, to be strong evidence of device e cacy since this association should be independent of the placebo effect, and instead be due to the proposed mechanisms of action associated with both treatments.…”

Section: Limitationsmentioning

confidence: 98%

Pulsed Shortwave Therapy in Cervical Osteoarthritis: An NSAID- Controlled, Randomized Clinical Trial

Mohameed¹,

Koneru

Staelin

et al. 2020

Preprint

View full text Add to dashboard Cite

Objective Assess treatment superiority of Pulsed Shortwave Therapy (PSWT) against COX-2 NSAID therapy, in reducing disability and pain due to cervical osteoarthritis.Design 200chronic pain suffers (average pain duration about 2 years)diagnosed with cervical osteoarthritis by radiological imaging were randomized into one of two treatmentarms: COX-2 NSAID treatment: Etoricoxib 60mg/day for 4 weeks; or, PSWT treatmentworn 24 hours/day for 4 weeks. The primary outcome measure was the 4-week score on the Neck Disability Index (NDI): a 10-question assessment on a 50-point scale. Secondary outcome measures included pain(at rest and during activity)measured on a Visual Analog Scale (VAS)of0-100 mm, dose count of rescue pain medication (paracetamol)use and a treatment satisfaction rating. These 4-week scores were compared across the two arms to assess superiority.Results After 4 weeks of treatment,subjects in both study arms reported significantly lower (p<0.0001) 4-week measures (11.24-NSAID;9.34-PSWT; 0-50 points),VASrest (30.08-NSAID;22.76-PSWT; 0-100 mm) and VASactivity (36.40-NSAID; 27.42-PSWT; 0-100 mm).The absolute reduction from baseline in NDI was significantly greater in the PSWT arm than NSAID arm(by 3.66 points; 95% CI 2.3 to 5.02; p<0.0001). Similarly, the reductions from baseline inVASrest and VASactivitywere significantly greater in the PSWT arm than NSAID arm(by 10.89 mm;95% CI 6.90 to 14.87; p<0.0001 and 12.05 mm;95% CI 7.76 to 16.33; p<0.0001 respectively).The PSWT arm used 50% less rescue pain medication. Eleven adverse effects were reported in the NSAID arm and zero in the PSWT arm.Conclusion Both NSAID and PSWT treatments resulted in clinically meaningful increases in quality of life(NDI) and decreases in pain (VAS) associated with cervicalosteoarthritis. However, the PSWT armshowed superior improvements in all outcome measures when compared to the NSAID armwith no adverse effects.

show abstract

“…Alguns estudos relatam também a utilização de procedimentos diferenciados para alívio da dor, edema e trismo pós-operatórios, como o uso de crioterapia, aplicação de laser, utilização de campo eletromagnético pulsátil entre outros (POUCHAIN et al, 2015;STOCCHERO et al, 2015).…”

Section: Métodounclassified

Comparação da eficácia clínica do naproxeno, associado ou não ao esomeprazol, no controle da dor, edema e trismo em exodontias deterceiros molares inferiores

Weckwerth¹

View full text Add to dashboard Cite

Comparison of the clinical efficacy of naproxen, associated or not with esomeprazole, in the control of pain, swelling and trismus in lower third molar removal Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to manage postoperative pain and inflammation in patients after oral and maxillofacial surgery, yet they are often associated with gastrointestinal problems. Recently the NSAID naproxen was introduced in combination with esomeprazole, a proton pump inhibitor that reduces stomach acid formation, in an effort to assuage these side effects. Using a double-blinded randomized crossover design, this study aimed to evaluate, for the first time, acute postoperative pain management in 46 volunteers who consumed a tablet of either naproxen (500 mg) with esomeprazole (20 mg) (NE) or only naproxen (500 mg) every 12 hours for 4 days after extractions of the two lower third molars, in two different appointments. Female volunteers reported significantly more pain at 1, 1.5, 2, 3 and 4 hours after surgery and also consumed their first rescue medication (acetaminophen) at a time significantly earlier when consuming NE when compared to naproxen (3.7 hours and 6.7 hours, respectively). No significant differences were found in the males between each research group. In conclusion, naproxen improved acute postoperative pain management when compared to NE in women although, throughout the entire study, pain was mild after the use of both drugs in both men and women with pain scores on average well below 40 mm on the VAS.

show abstract

Pulsed electromagnetic fields for postoperative pain: a randomized controlled clinical trial in patients undergoing mandibular third molar extraction

Cited by 19 publications

References 39 publications

Pulsed Electromagnetic Fields for Postsurgical Pain Management in Women Undergoing Cesarean Section

Pulsed Electromagnetic Fields for Postsurgical Pain Management in Women Undergoing Cesarean Section

Pulsed Shortwave Therapy in Cervical Osteoarthritis: An NSAID- Controlled, Randomized Clinical Trial

Comparação da eficácia clínica do naproxeno, associado ou não ao esomeprazol, no controle da dor, edema e trismo em exodontias deterceiros molares inferiores

Contact Info

Product

Resources

About